Insider Cluster (2 insiders) ·Filed Aug 27, 2026

GILD

GILEAD SCIENCES, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $926K total
Actionable Insight • Neutral

No actionable signal. Director-level cashless exercise-and-sell transactions at 0.0005% of market cap are routine and non-informative. Monitor for C-suite open-market sales or purchases at materially larger scale (>$10M) before reading any directional signal.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
GILD ▲ +4.48% at T+20d
NEUTRAL call ✓ call won +4.48% · α vs SPY +4.22% · entry $145.68 → $152.21
Next anchor: T+60d in 7w
Latest observation: T+23 -0.11% FF3 residual α
Entry anchored
Aug 27, 06:41 PM ET
via 1-min bar
T+1d
+0.45%
call +0.45% · α +0.75%
$146.34
settled 5w ago
T+5d
+3.65%
call +3.65% · α +3.54%
$151.00
settled 29d ago
T+20d
+4.48%
call +4.48% · α +4.22%
$152.21
settled 7d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

Two GILD directors sold a combined $926K in open-market sales over a one-week window. Director Anthony Welters executed a multi-leg transaction on Aug 26 — exercising derivative options at $0 and $60.67-$61.35 strike prices, then immediately selling the resulting shares at ~$148.82 for $685K in proceeds. Director Jeffrey Bluestone sold 1.7K shares at $145.73 for $242K on Aug 20. The total open-market sale value of $926K represents approximately 0.0005% of GILD's $183.6B market cap — a trivial amount that falls well below the 0.1% materiality threshold. These are routine cashless exercise-and-sell transactions by directors, not informed selling.

Key Financial Metrics

Direction
selling
Total Value
$926.0K
Insiders
2

Key Facts

  • Two directors sold a combined $926K in open-market sales over 7 days
  • Total sales represent ~0.0005% of GILD's $183.6B market cap
  • Director Welters exercised 28,282 derivative shares at $0-$61.35, then sold 18,000 shares at ~$148.82
  • Director Bluestone sold 1,700 shares at $145.73 for $242K
  • All sales are cashless exercise-and-sell transactions, not conviction sells

Financial Impact

$926K in open-market sales, 0.0005% of market cap — immaterial

Risk Factors

  • None — transaction value is trivial relative to market cap

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
81% bullish (37 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GILD-1787872138733
16 reports for GILD
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+60▲ +16.72%Jul 6, 2026
Filters
Rows
Reports for GILD — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$149.61 $149.05▼ −0.37%▼ −0.04%$144.74 (−3.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$145.68 $152.21▲ +4.48%▲ +4.22%$144.74 (−0.65%)
Aug 21, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$146.74 $152.67▲ +4.04%▲ +2.73%$144.74 (−1.36%)
Aug 18, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$147.60 $150.89▲ +2.23%▲ +4.18%$144.74 (−1.94%)
Aug 18, 2026
6w ago
Court Ruling
BULLISH ★ 7/10
$143.44 $147.68▲ +2.96%▲ +4.27%$144.74 (+0.91%)
Aug 13, 2026
7w ago
Court Ruling
BULLISH ★ 6/10
$138.14 $143.72▲ +4.04%▲ +5.79%$144.74 (+4.78%)
Aug 6, 2026
8w ago
S-3ASR
NEUTRAL ★ 2/10
$133.21 $151.00▲ +13.35%▲ +13.75%$144.74 (+8.66%)
Jul 21, 2026
10w ago
ANALYST-DOWNGRADE
BEARISH ★ 4/10
$130.28 $143.44▼ −10.10%▼ −7.54%$144.74 (−11.10%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$134.28 $138.33▲ +3.02%▼ −1.43%$144.74 (+7.79%)
Jul 6, 2026
12w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$129.61 $130.21▲ +0.46%▲ +1.03%$144.74 (+11.67%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (65h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 27, 2026